본문 바로가기

Local delivery of a cancer-favoring oncolytic vaccinia virus via poly (lactic-co-glycolic acid) nanofiber for theranostic purposes

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
INTERNATIONAL JOURNAL OF PHARMACEUTICS552(1-2) · pp.437 · 2018
피인용
Web of Science 34Scopus 39
FWCI (Scopus)
1.7
JCR IF
JCR 2017 3.862
ISSN
0378-5173

저자

  1. 바드리나트 나라아나사미제1저자Biomedical Science, School of Medicine, Pusan National University, Yangsan, South Korea
  2. 정영일Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea
  3. 우현영Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
  4. 방서영BIO-IT Foundry Technology Institute, Pusan National University, Busan, South Korea
  5. Kim, ChanAmogreentech Co. Ltd. Gyeonggi-do, South Korea
  6. 허정Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
  7. 강대환Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
  8. 유소영교신저자Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea

초록

Local delivery of viruses via nanomaterials has been demonstrated in the treatment of colon cancer. A cancer-favoring oncolytic vaccinia virus (CVV), which is an evolutionary cancer-favoring engineered vaccinia virus carrying the green fluorescent protein (GFP) gene, has antitumor efficacy in drug-resistant colon cancer and metastatic liver cells. Here, we present the antitumor efficacy of a CVV coated a poly lactic-co-glycolic acid (PLGA) nanofiber for local drug delivery in theranostic approaches. In vitro- and in vivo-based analyses using mouse colon carcinoma models confirmed the therapeutic efficacy of CVV-PLGA nanofibers through diagnostic localization of the tumors and reduced tumor burden as a result of enhanced apoptosis. We propose that the CVV-PLGA nanofiber may be used for theranostic purposes in cancer therapy.

키워드

Poly (lactic-co-glycolic acid) nanofibersCancer-favoring oncolytic vaccinia virusCancer therapyTheranosticsHEPATOCELLULAR-CARCINOMAIN-VITROCONTROLLED-RELEASECOLORECTAL-CANCERLIVER-CANCERPOXVIRUSJX-594PLGATHERAPYNANOPARTICLES

식별자

Scopus EID
2-s2.0-85054655559
WoS UID
000447985800048